DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Xanthine

Xanthine

  • SCH 58261: a Potent and Selective Non-Xanthine A2A Adenosine Receptor Antagonist

    SCH 58261: a Potent and Selective Non-Xanthine A2A Adenosine Receptor Antagonist

  • Effect of Theophylline and Enprofylline on Bronchial Hyperresponsiveness

    Effect of Theophylline and Enprofylline on Bronchial Hyperresponsiveness

  • Pro-Aging Effects of Xanthine Oxidoreductase Products

    Pro-Aging Effects of Xanthine Oxidoreductase Products

  • COPD Agents Review – October 2020 Page 2 | Proprietary Information

    COPD Agents Review – October 2020 Page 2 | Proprietary Information

  • (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen Et Al

    (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen Et Al

  • Nouriast Tablets 20 Mg [Non-Proprietary Name] Istradefylline (JAN*) [Applicant] Kyowa Hakko Kirin Co., Ltd

    Nouriast Tablets 20 Mg [Non-Proprietary Name] Istradefylline (JAN*) [Applicant] Kyowa Hakko Kirin Co., Ltd

  • A 1 Adenosine Receptor Agonists and Antiagonists

    A 1 Adenosine Receptor Agonists and Antiagonists

  • In-Silico Approaches

    In-Silico Approaches

  • Methylxanthines and Neurodegenerative Diseases: an Update

    Methylxanthines and Neurodegenerative Diseases: an Update

  • V Olume 51 • Issue 2 • a Ugust 2021

    V Olume 51 • Issue 2 • a Ugust 2021

  • Xanthine (116900) and Oxypurinol (447509) Technical Document

    Xanthine (116900) and Oxypurinol (447509) Technical Document

  • PDL DRUG REVIEW Proprietary Name: Nourianz® Common Name: Istradefylline PDL Category: Anti‐Parkinsonian Drugs

    PDL DRUG REVIEW Proprietary Name: Nourianz® Common Name: Istradefylline PDL Category: Anti‐Parkinsonian Drugs

  • Ehealth DSI [Ehdsi V2.2.1] European Commission

    Ehealth DSI [Ehdsi V2.2.1] European Commission

  • Clinical Applications of Serum Theophylline Measurement by High Pressure Liquid Chromatography

    Clinical Applications of Serum Theophylline Measurement by High Pressure Liquid Chromatography

  • Study Protocol 1

    Study Protocol 1

  • (RAP) Title : Reporting and Analysis Plan for St

    (RAP) Title : Reporting and Analysis Plan for St

  • Download Product Insert (PDF)

    Download Product Insert (PDF)

  • CDR Pharmacoeconomic Review Report for Trelegy Ellipta

    CDR Pharmacoeconomic Review Report for Trelegy Ellipta

Top View
  • Diccionario Del Sistema De Clasificación Anatómica, Terapéutica, Química - ATC CATALOGO SECTORIAL DE PRODUCTOS FARMACEUTICOS
  • Adenosine Receptor P1 Receptor
  • Convergent Evolution of Caffeine in Plants by Co-Option of Exapted Ancestral Enzymes
  • Curcumin Potentiates 7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress
  • Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol
  • Unique Role of Caffeine Compared to Other Methylxanthines
  • Ep 2301628 A1
  • New Drug Update 2015-16 April 2016
  • Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical Development S
  • Diphylline | Medchemexpress
  • Tumor Immunotherapy Using A2A Adenosine Receptor Antagonists
  • Chem. Pharm. Bull. 66(6): 620-623 (2018)
  • Safety Assessment of Xanthine Alkaloids As Used in Cosmetics
  • OTHER REVIEW(S) FOOD and DRUG ADMINISTRATION Center for Drug Evaluation and Research Office of Prescription Drug Promotion ****Pre-Decisional Agency Information****
  • Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
  • Justification
  • Methylxanthines Induce Structural and Functional Alterations of the Cardiac
  • PRODUCT INFORMATION SCH 58261 Item No


© 2024 Docslib.org    Feedback